Fundraising FoxDigitalis Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.
BiotechHealthtechAustin, US
Anand Parikh(Executive Officer, Director, Promoter)inOliver Maddocks(Executive Officer, Director)inChristopher W. Gerry(President and General Counsel)
BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)
Co-investorsAble PartnersAtacama VenturesCota CapitalFuture VenturesiSelect FundS2G Investments+7 more
Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.
BiotechHealthtechMedical DevicesSan Diego, US
Aaron Hirschhorn(Founder)Linda Black(Chief Executive Officer; founding team member)inDavis Brimer(Executive Officer, Director)Beau Becker(Head of Strategic Operations & People Effectiveness; founding team member)in
BoardTeymour Boutros-Ghali(Director)inValentine Williams(DVM, MS, Diplomate ACVS)
Board seatMisti Ushio· per SEC Form D
Co-investorsAlpha EdisonAlumni VenturesBaroda VenturesBling CapitalBold Capital PartnersExpansion Venture Capital+3 more
Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Diego, US
Brent J. Warner(Executive Officer, Director)inXIN JIANG(President & CEO)inHANK MICHAEL PETRASSI(Executive Officer)JEFFERY KELLY(Director)
BoardTIM LOHOFF(Director)Edward Hurwitz(Director)
Co-investorsDroia VenturesNovartis Venture FundForbionLightspeed Venture PartnersMPM BioImpactVida Ventures+1 more
Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities.
Digital HealthHealthtechImpact & Social GoodMental HealthMinneapolis, US
Justin Ley(CEO)inMatt(Chief Product Officer)
BoardHelen Ciesielski(Director)inMatthew Swanson(Director)Ellen Herlacher(Director)inAmon Anderson(Director)
Co-investorsGROOVE CAPITALHC9 VenturesHeadwater VenturesLRVHealthMaC Venture CapitalMatchstick Ventures+3 more
.png)
Tenvie is a clinical-stage biopharmaceutical company developing small molecule and biologic therapeutics for neurological and peripheral diseases.
BiotechMedical Devices
Tony Estrada(President & Chief Executive Officer; co-founder)in
Co-investorsARCH Venture PartnersF-Prime CapitalBain Capital Life SciencesForbionMubadala Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.